Disclosure of elevated amyloid status is not associated with long‐term suicidality in a preclinical AD trial - Grill, Joshua D.; Raman, Rema; Flournoy, Charlene; Ernstrom, Karin; Pierce, Aimee; Smith, Amanda; Rosenberg, Paul; Burns, Jeffrey; Karlawish, Jason; Aisen, Paul; Holdridge, Karen Chilcott; Mancini, Michele; et al. (Alzheimer's & dementia, 2025)
Keywords: Aged; Aged, 80 and over; Alzheimer Disease - diagnostic imaging; Alzheimer Disease - metabolism; Alzheimer Disease - psychology; Amyloid - metabolism; Amyloid beta-Peptides - metabolism; biomarker; Biomarkers - metabolism; Brain - diagnostic imaging; Brain - metabolism; Cohort Studies; Disclosure; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; preclinical; Short Report; Suicidal Ideation; suicide; Suicide - psychology; disclosure; biomarker; preclinical; suicide